MGMT-535G> T POLYMORPHISM IS ASSOCIATED WITH PROGNOSIS FOR PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH OXALIPLATIN-BASED CHEMOTHERAPY

被引：0
|
作者：
Kang, B. W. [1 ]
Kim, J. G. [1 ]
Chae, Y. S. [1 ]
Lee, S. J. [1 ]
Do, Y. R. [2 ]
Lee, W. S. [3 ]
机构：
[1] Kyungpook Natl Univ Hosp, Taegu, South Korea
[2] Dongsan Med Ctr, Taegu, South Korea
[3] Daegu Fatima Hosp, Ctr Canc, Taegu, South Korea
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：209 / 210
页数：2
相关论文
共 50 条
  • [41] Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Advanced Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy
    Kaneko, Manabu
    Nozawa, Hiroaki
    Sasaki, Kazuhito
    Hongo, Kumiko
    Hiyoshi, Masaya
    Tada, Noriko
    Murono, Koji
    Nirei, Takako
    Kawai, Kazushige
    Sunami, Eiji
    Tsuno, Nelson H.
    Kitayama, Joji
    ONCOLOGY, 2012, 82 (05) : 261 - 268
  • [42] Oxaliplatin-based chemotherapy in association with highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients
    Berretta, M
    Simonelli, C
    Lleshi, A
    Lacchin, T
    Bearz, A
    di Gennaro, G
    Vaccher, E
    Tirelli, U
    ANNALS OF ONCOLOGY, 2006, 17 (04) : 721 - 722
  • [43] USE OF OXALIPLATIN-BASED CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC): A POST-HOC ANALYSIS OF THE GLUTOX STUDY
    Benoit, Samson
    Pierre, Dube
    Nathalie, Aucoin
    Rafal, Wierzbicki
    Jean, Maroun
    Richard, Letourneau
    Eric, Chen
    Danielle, Charpentier
    Felix, Couture
    Mark, Vincent
    Jean, Lepine
    Pierre, Whitlock
    Karine, Alloul
    Francois, Leblond
    Wei, Zhou
    Petr, Kavan
    ANNALS OF ONCOLOGY, 2014, 25
  • [44] Inflammatory cytokines and toxic effects of oxaliplatin-based chemotherapy in patients with colorectal cancer.
    Wang, X. S.
    Cleeland, C. S.
    Johnson, V. E.
    Reuben, J. M.
    Fogelman, D. R.
    Malekifar, M.
    Liao, K. E.
    Liu, P.
    Cohen, E. N.
    Gilmore, K. R.
    Eng, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [45] Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer
    Gerger, Armin
    El-Khoueiry, Anthony
    Zhang, Wu
    Yang, Dongyun
    Singh, Harpreet
    Bohanes, Pierre
    Ning, Yan
    Winder, Thomas
    LaBonte, Melissa J.
    Wilson, Peter M.
    Benhaim, Leonor
    Paez, David
    El-Khoueiry, Rita
    Absenger, Gudrun
    Lenz, Heinz-Josef
    CLINICAL CANCER RESEARCH, 2011, 17 (17) : 5783 - 5792
  • [46] Tandemrepeat variation in HIC1 gene predicts outcome for oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
    Okazaki, S.
    Loupakis, F.
    Schirripa, M.
    Cao, S.
    Zhang, W.
    Yang, D.
    Ning, Y.
    Berger, M. D.
    Miyamoto, Y.
    Suenaga, M.
    Gopez, R.
    Borelli, B. B.
    Cremolini, C.
    Falcone, A.
    Lonardi, S.
    Salvatore, L.
    Uetake, H.
    Kawano, T.
    Helentjaris, T.
    Lenz, H-J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [47] Impact of Oxaliplatin-based chemotherapy on the haemoglobin levels: A retrospective analysis in patients with colorectal cancer
    Queralt, Bernardo
    Juez, Ignacio
    Hernandez, Xavier
    Vinas, Gemma
    Rubio, Jordi
    Soler, Francesc
    Monleon, Antonio
    Colomer, Ramon
    ANNALS OF ONCOLOGY, 2004, 15 : 86 - 86
  • [48] phase II study of oxaliplatin-based regimen in relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: INSPIRE study
    Kotaka, M.
    Ishibashi, K.
    Satake, H.
    Tsuji, Y.
    Kataoka, M.
    Nakamura, M.
    Nagata, N.
    Sakamoto, J.
    Oba, K.
    Mishima, H.
    ANNALS OF ONCOLOGY, 2020, 31 : S101 - S101
  • [49] -93G>A polymorphism of hMLH1 associated with prognosis for patients with colorectal cancer
    Kim, J.
    Chae, Y.
    Sohn, S.
    Kang, B.
    Lee, S.
    Lim, K.
    Choi, G.
    Baek, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study)
    Keiichiro Ishibashi
    Toru Aoyama
    Masahito Kotaka
    Hironaga Satake
    Yasushi Tsuji
    Masato Kataoka
    Masato Nakamura
    Naoki Nagata
    Junichi Sakamoto
    Koji Oba
    Hideyuki Mishima
    Cancer Chemotherapy and Pharmacology, 2021, 87 : 665 - 672
12345